Comprehensive Observations of Co-occurrence of MPN Driver Mutations: JAK2, CALR, and MPL

被引：0
|
作者：
Ollila, P. [1 ]
Artymiuk, C. [1 ]
Bessonen, K. [1 ]
Boerger, A. [1 ]
Dina, M. [1 ]
Mai, M. [1 ]
Shi, M. [1 ]
Wang, R. [1 ]
Yuan, J. [1 ]
Zhang, X. [1 ]
Viswanatha, D. [1 ]
He, R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
H014
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [31] A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients
    Xu, Na
    Ding, Li
    Yin, Changxin
    Zhou, Xuan
    Li, Lin
    Li, Yulin
    Lu, Qisi
    Liu, Xiao-li
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 865 - 867
  • [32] A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients
    Na Xu
    Li Ding
    Changxin Yin
    Xuan Zhou
    Lin Li
    Yulin Li
    Qisi Lu
    Xiao-li Liu
    Annals of Hematology, 2015, 94 : 865 - 867
  • [33] A case of very rare co-occurrence of POEMS syndrome and JAK2 V617F positive MPN
    Alaikov, Tzvetan
    Angelova, Svetlana
    Hristova, Julieta
    Ivanova, Milena
    Shivarov, Velizar
    JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (01) : 23 - 26
  • [34] A case of very rare co-occurrence of POEMS syndrome and JAK2 V617F positive MPN
    Tzvetan Alaikov
    Svetlana Angelova
    Julieta Hristova
    Milena Ivanova
    Velizar Shivarov
    Journal of Hematopathology, 2018, 11 : 23 - 26
  • [35] The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients
    Dayyeni, Aseel M. Al
    Al-Gailani, Bassam T.
    Mahdi, Mohammed Ghanim
    Khazeem, Mushtaq M.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E443 - E451
  • [36] The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients
    Dayyeni, Aseel M. Al
    Al-Gailani, Bassam T.
    Mahdi, Mohammed Ghanim
    Khazeem, Mushtaq M.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E443 - E451
  • [37] Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations
    Stephen E. Langabeer
    Karl Haslam
    Jennifer Linders
    Melanie J. Percy
    Eibhlin Conneally
    Amjad Hayat
    Brian Hennessy
    Maeve Leahy
    Karen Murphy
    Margaret Murray
    Fionnuala Ni Ainle
    Patrick Thornton
    Jeremy Sargent
    Familial Cancer, 2014, 13 : 659 - 663
  • [38] Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations
    Langabeer, Stephen E.
    Haslam, Karl
    Linders, Jennifer
    Percy, Melanie J.
    Conneally, Eibhlin
    Hayat, Amjad
    Hennessy, Brian
    Leahy, Maeve
    Murphy, Karen
    Murray, Margaret
    Ainle, Fionnuala Ni
    Thornton, Patrick
    Sargent, Jeremy
    FAMILIAL CANCER, 2014, 13 (04) : 659 - 663
  • [39] A Rare Case of Essential Thrombocythemia Progressed to Acute Myeloid Leukemia with Concomitant JAK2, CALR, and MPL Mutations
    Hsu, J.
    Thomas, J.
    Hodjat, P.
    Li, Z.
    Sura, G.
    Olsen, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S48 - S48
  • [40] JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
    Shirane, Shuichi
    Araki, Marito
    Morishita, Soji
    Edahiro, Yoko
    Takei, Hiraku
    Yoo, Yongjin
    Choi, Murim
    Sunami, Yoshitaka
    Hironaka, Yumi
    Noguchi, Masaaki
    Koike, Michiaki
    Noda, Naohiro
    Ohsaka, Akimichi
    Komatsu, Norio
    HAEMATOLOGICA, 2015, 100 (02) : E46 - E48
12345